122 results  1 of 7 

1 Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
Sun Mi Cho, Hye Sun Lee, Soyoung Jeon, Yoonjung Kim, Sun-Young Kong, Jin Kyung Lee, Kyung-A Lee
Ann Lab Med.2023;43(6):605-613.   Published online 2023 June 30     DOI: http://dx.doi.org/10.3343/alm.2023.43.6.605
      
2 EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.2023;55(2):498-505.   Published online 2022 October 4     DOI: http://dx.doi.org/10.4143/crt.2022.388
      
3 Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Byoung Chul Cho, Dong-Wan Kim, Ullas Batra, Keunchil Park, Sang-We Kim, Cheng-Ta Yang, Pei-Jye Voon, Virote Sriuranpong, K. Govind Babu, Khalid Amin, Yingbo Wang, Paramita Sen, Khemaies Slimane, Sarayut Geater
Cancer Res Treat.2023;55(1):83-93.   Published online 2022 March 25     DOI: http://dx.doi.org/10.4143/crt.2021.1571
      
4 Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
Inwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Han
Cancer Res Treat.2022;54(3):782-792.   Published online 2021 November 23     DOI: http://dx.doi.org/10.4143/crt.2021.843
      
5 The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non–Small Cell Lung Cancer
Noeul Kang, Ki Hwan Kim, Byeong-Ho Jeong, Kyungjong Lee, Hojoong Kim, O Jung Kwon, Myung-Ju Ahn, Jeonghee Cho, Ho Yun Lee, Sang-Won Um
Cancer Res Treat.2022;54(3):817-826.   Published online 2021 November 9     DOI: http://dx.doi.org/10.4143/crt.2021.822
      
6 Usefulness of Pulmonary Rehabilitation in Non–Small Cell Lung Cancer Patients Based on Pulmonary Function Tests and Muscle Analysis Using Computed Tomography Images
Juwhan Choi, Zepa Yang, Jinhwan Lee, Jun Hee Lee, Hyun Koo Kim, Hwan Seok Yong, Sung Yong Lee
Cancer Res Treat.2022;54(3):793-802.   Published online 2021 October 20     DOI: http://dx.doi.org/10.4143/crt.2021.769
      
7 Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.2022;54(2):458-468.   Published online 2021 September 10     DOI: http://dx.doi.org/10.4143/crt.2021.425
      
8 Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
J Pathol Transl Med.2021;55(3):181-191.   Published online 2021 May 11     DOI: http://dx.doi.org/10.4132/jptm.2021.03.23
      
9 Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.2022;54(1):150-156.   Published online 2021 May 6     DOI: http://dx.doi.org/10.4143/crt.2021.306
      
10 Pembrolizumab-related autoimmune hemolytic anemia in a patient with metastatic lung adenocarcinoma: a case report
Dong Won Baek, Yee Soo Chae
Yeungnam Univ J Med.2021;38(4):366-370.   Published online 2021 March 23     DOI: http://dx.doi.org/10.12701/yujm.2021.00899
      
11 The Clinical Impact of Capmatinib in the Treatment of Advanced Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification
Wonyoung Choi, Seog-Yun Park, Youngjoo Lee, Kun Young Lim, Minjoung Park, Geon Kook Lee, Ji-Youn Han
Cancer Res Treat.2021;53(4):1024-1032.   Published online 2021 January 29     DOI: http://dx.doi.org/10.4143/crt.2020.1331
      
12 Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
Min Ho Lee, Kyung-Rae Cho, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jung-Il Lee
J Korean Neurosurg Soc.2021;64(2):271-281.   Published online 2020 December 4     DOI: http://dx.doi.org/10.3340/jkns.2020.0135
      
13 Delphinidin enhances radio-therapeutic effects via autophagy induction and JNK/MAPK pathway activation in non-small cell lung cancer
Seong Hee Kang, Dong-Ho Bak, Byung Yeoup Chung, Hyoung-Woo Bai, Bo Sun Kang
Korean J Physiol Pharmacol.2020;24(5):413-422.   Published online 2020 September 1     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.5.413
      
14 Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
Myung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, Byoung Chul Cho, Jin-Hyoung Kang, Sang-We Kim, James Chih-Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee
Cancer Res Treat.2020;52(1):284-291.   Published online 2019 July 23     DOI: http://dx.doi.org/10.4143/crt.2019.200
      
15 Morphologic Evaluation of Primary Non-Small Cell Lung Cancer by 3 Tesla MRI with Free-Breathing Ultrashort Echo Time and Radial T1-Weighted Gradient Echo Sequences: A Comparison with CT Analysis
Hyunji Lee, EunHee Choi, Myoung Kyu Lee, Yu Zhang, Woocheol Kwon
J Korean Soc Radiol.2019;80(3):466-476.   Published online 2019 May 31     DOI: http://dx.doi.org/10.3348/jksr.2019.80.3.466
      
16 SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
Yoo-Kang Kwak, Hee Hyun Park, Kyu Hye Choi, Eun Young Park, Soo Yoon Sung, Sea-Won Lee, Ji Hyun Hong, Hyo Chun Lee, Ie Ryung Yoo, Yeon Sil Kim
Cancer Res Treat.2020;52(1):85-97.   Published online 2019 May 17     DOI: http://dx.doi.org/10.4143/crt.2019.007
      
17 Clinical Significance of Pleural Attachment and Indentation of Subsolid Nodule Lung Cancer
Hyung-Jun Kim, Jun Yeun Cho, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Jin-Haeng Chung, Sukki Cho, Kwhanmien Kim, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
Cancer Res Treat.2019;51(4):1540-1548.   Published online 2019 March 25     DOI: http://dx.doi.org/10.4143/crt.2019.057
      
18 Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
Ha-Young Park, In-Jae Oh, Bo Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Cheol Kyu Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Yoo-Duk Choi
Tuberc Respir Dis.2019;82(3):227-233.   Published online 2019 February 28     DOI: http://dx.doi.org/10.4046/trd.2018.0070
      
19 Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
Dong Hoon Shin, Hyo Sup Shim, Tae Jung Kim, Heae Surng Park, Yun La Choi, Wan Seop Kim, Lucia Kim, Sun Hee Chang, Joon Seon Song, Hyo jin Kim, Jung Ho Han, Chang Hun Lee, Geon Kook Lee, Se Jin Jang
J Pathol Transl Med.2019;53(3):153-158.   Published online 2019 February 28     DOI: http://dx.doi.org/10.4132/jptm.2019.02.22
      
20 The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
Jong Hyun Choi, Juwhan Choi, Sang Mi Chung, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Hyun Kyung Lee, Sung Yong Lee
Tuberc Respir Dis.2019;82(3):211-216.   Published online 2018 December 20     DOI: http://dx.doi.org/10.4046/trd.2018.0019
      

 1 of 7